Mustang Bio, Inc. announced that its IL13Ra2-targeted CAR T-cell therapy, MB-101, received Orphan Drug Designation from the FDA for treating recurrent diffuse and anaplastic astrocytomas and ...
Community started off the semester with a solid premiere. While “Biology 101” didn’t induce any real belly laughs, the addition of two new guest stars more than made up for it. Hello John Goodman and ...
Remember Biology 101? I sure do. It was the first class I had in my first semester in college at the ripe age of 18. It started at 7:30 in the morning, whether or not I did, and was taught by one of ...
Greendale Community College’s very own answer to the Breakfast Club is back, as the new school year kicks off with Biology 101. Despite the pre-season talk of normalcy and appealing to a broader ...
Latus Bio Inc. is developing a new gene therapy, LTS-101, for the treatment of neuronal ceroid lipofuscinosis type2 (CLN2), a form of Batten disease characterized by deficiency in the tripeptidyl ...
Latus Bio Inc. has reported IND clearance by the FDA for LTS-101, a gene therapy candidate to treat the CNS manifestations of late-infantile neuronal ceroid lipofuscinosis type 2 (CLN2) disease. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback